世界の上気道感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Upper Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6058
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、上気道感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬 (NSAIDs) ＆鼻充血除去薬、その他）、用途別市場規模（鼻炎、副鼻腔炎、鼻咽頭炎、喉頭蓋炎、喉頭炎、百日咳、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・上気道感染症治療の市場動向
・企業の競争状況、市場シェア
・上気道感染症治療の種類別市場規模と予測2016-2027（抗生物質、非ステロイド性抗炎症薬 (NSAIDs) ＆鼻充血除去薬、その他）
・上気道感染症治療の用途別市場規模と予測2016-2027（鼻炎、副鼻腔炎、鼻咽頭炎、喉頭蓋炎、喉頭炎、百日咳、その他）
・上気道感染症治療の北米市場規模2016-2027（アメリカ、カナダ）
・上気道感染症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・上気道感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・上気道感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・上気道感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline Plc、Merck & Co., Inc.、Pfizer Inc.、Regeneron Pharmaceuticals Inc.、Teva Pharmaceutical Industries Ltd.）
・結論

Rhinitis, sinusitis, nasopharyngitis, epiglottitis, laryngitis, and whooping cough are some of the types of upper respiratory tract infections.
It can be treated with various drugs such as azithromycin, doxycycline, xylometazoline, propylhexedrine, amoxicillin, clarithromycin, aspirin, ibuprofen, erythromycin, and ephedrine, which target disease-causing pathogens such as bacteria and viruses.

Market Analysis and Insights: Global Upper Respiratory Tract Infection Treatment Market
The global Upper Respiratory Tract Infection Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Upper Respiratory Tract Infection Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Upper Respiratory Tract Infection Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Upper Respiratory Tract Infection Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Upper Respiratory Tract Infection Treatment market.

Global Upper Respiratory Tract Infection Treatment Scope and Market Size
Upper Respiratory Tract Infection Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Upper Respiratory Tract Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibiotics
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Nasal Decongestants
Others

Segment by Application
Rhinitis
Sinusitis
Nasopharyngitis
Epiglottitis
Laryngitis
Whooping Cough
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline Plc
Merck & Co., Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Upper Respiratory Tract Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Nasal Decongestants
1.2.4 Others
1.3 Market by Application
1.3.1 Global Upper Respiratory Tract Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Rhinitis
1.3.3 Sinusitis
1.3.4 Nasopharyngitis
1.3.5 Epiglottitis
1.3.6 Laryngitis
1.3.7 Whooping Cough
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Upper Respiratory Tract Infection Treatment Market Perspective (2016-2027)
2.2 Upper Respiratory Tract Infection Treatment Growth Trends by Regions
2.2.1 Upper Respiratory Tract Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Upper Respiratory Tract Infection Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Upper Respiratory Tract Infection Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Upper Respiratory Tract Infection Treatment Industry Dynamic
2.3.1 Upper Respiratory Tract Infection Treatment Market Trends
2.3.2 Upper Respiratory Tract Infection Treatment Market Drivers
2.3.3 Upper Respiratory Tract Infection Treatment Market Challenges
2.3.4 Upper Respiratory Tract Infection Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Upper Respiratory Tract Infection Treatment Players by Revenue
3.1.1 Global Top Upper Respiratory Tract Infection Treatment Players by Revenue (2016-2021)
3.1.2 Global Upper Respiratory Tract Infection Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Upper Respiratory Tract Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Upper Respiratory Tract Infection Treatment Revenue
3.4 Global Upper Respiratory Tract Infection Treatment Market Concentration Ratio
3.4.1 Global Upper Respiratory Tract Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Upper Respiratory Tract Infection Treatment Revenue in 2020
3.5 Upper Respiratory Tract Infection Treatment Key Players Head office and Area Served
3.6 Key Players Upper Respiratory Tract Infection Treatment Product Solution and Service
3.7 Date of Enter into Upper Respiratory Tract Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Upper Respiratory Tract Infection Treatment Breakdown Data by Type
4.1 Global Upper Respiratory Tract Infection Treatment Historic Market Size by Type (2016-2021)
4.2 Global Upper Respiratory Tract Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Upper Respiratory Tract Infection Treatment Breakdown Data by Application
5.1 Global Upper Respiratory Tract Infection Treatment Historic Market Size by Application (2016-2021)
5.2 Global Upper Respiratory Tract Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Upper Respiratory Tract Infection Treatment Market Size (2016-2027)
6.2 North America Upper Respiratory Tract Infection Treatment Market Size by Type
6.2.1 North America Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2021)
6.2.2 North America Upper Respiratory Tract Infection Treatment Market Size by Type (2022-2027)
6.2.3 North America Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2027)
6.3 North America Upper Respiratory Tract Infection Treatment Market Size by Application
6.3.1 North America Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2021)
6.3.2 North America Upper Respiratory Tract Infection Treatment Market Size by Application (2022-2027)
6.3.3 North America Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2027)
6.4 North America Upper Respiratory Tract Infection Treatment Market Size by Country
6.4.1 North America Upper Respiratory Tract Infection Treatment Market Size by Country (2016-2021)
6.4.2 North America Upper Respiratory Tract Infection Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Upper Respiratory Tract Infection Treatment Market Size (2016-2027)
7.2 Europe Upper Respiratory Tract Infection Treatment Market Size by Type
7.2.1 Europe Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2021)
7.2.2 Europe Upper Respiratory Tract Infection Treatment Market Size by Type (2022-2027)
7.2.3 Europe Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2027)
7.3 Europe Upper Respiratory Tract Infection Treatment Market Size by Application
7.3.1 Europe Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2021)
7.3.2 Europe Upper Respiratory Tract Infection Treatment Market Size by Application (2022-2027)
7.3.3 Europe Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2027)
7.4 Europe Upper Respiratory Tract Infection Treatment Market Size by Country
7.4.1 Europe Upper Respiratory Tract Infection Treatment Market Size by Country (2016-2021)
7.4.2 Europe Upper Respiratory Tract Infection Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size (2016-2027)
8.2 Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Type
8.2.1 Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Application
8.3.1 Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Region
8.4.1 Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Upper Respiratory Tract Infection Treatment Market Size (2016-2027)
9.2 Latin America Upper Respiratory Tract Infection Treatment Market Size by Type
9.2.1 Latin America Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Upper Respiratory Tract Infection Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2027)
9.3 Latin America Upper Respiratory Tract Infection Treatment Market Size by Application
9.3.1 Latin America Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Upper Respiratory Tract Infection Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2027)
9.4 Latin America Upper Respiratory Tract Infection Treatment Market Size by Country
9.4.1 Latin America Upper Respiratory Tract Infection Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Upper Respiratory Tract Infection Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size (2016-2027)
10.2 Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Type
10.2.1 Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Application
10.3.1 Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Country
10.4.1 Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline Plc
11.1.1 GlaxoSmithKline Plc Company Details
11.1.2 GlaxoSmithKline Plc Business Overview
11.1.3 GlaxoSmithKline Plc Upper Respiratory Tract Infection Treatment Introduction
11.1.4 GlaxoSmithKline Plc Revenue in Upper Respiratory Tract Infection Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Plc Recent Development
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Details
11.2.2 Merck & Co., Inc. Business Overview
11.2.3 Merck & Co., Inc. Upper Respiratory Tract Infection Treatment Introduction
11.2.4 Merck & Co., Inc. Revenue in Upper Respiratory Tract Infection Treatment Business (2016-2021)
11.2.5 Merck & Co., Inc. Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Details
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. Upper Respiratory Tract Infection Treatment Introduction
11.3.4 Pfizer Inc. Revenue in Upper Respiratory Tract Infection Treatment Business (2016-2021)
11.3.5 Pfizer Inc. Recent Development
11.4 Regeneron Pharmaceuticals Inc.
11.4.1 Regeneron Pharmaceuticals Inc. Company Details
11.4.2 Regeneron Pharmaceuticals Inc. Business Overview
11.4.3 Regeneron Pharmaceuticals Inc. Upper Respiratory Tract Infection Treatment Introduction
11.4.4 Regeneron Pharmaceuticals Inc. Revenue in Upper Respiratory Tract Infection Treatment Business (2016-2021)
11.4.5 Regeneron Pharmaceuticals Inc. Recent Development
11.5 Teva Pharmaceutical Industries Ltd.
11.5.1 Teva Pharmaceutical Industries Ltd. Company Details
11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd. Upper Respiratory Tract Infection Treatment Introduction
11.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Upper Respiratory Tract Infection Treatment Business (2016-2021)
11.5.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Upper Respiratory Tract Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Nasal Decongestants
Table 4. Key Players of Others
Table 5. Global Upper Respiratory Tract Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Upper Respiratory Tract Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Upper Respiratory Tract Infection Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Upper Respiratory Tract Infection Treatment Market Share by Regions (2016-2021)
Table 9. Global Upper Respiratory Tract Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Upper Respiratory Tract Infection Treatment Market Share by Regions (2022-2027)
Table 11. Upper Respiratory Tract Infection Treatment Market Trends
Table 12. Upper Respiratory Tract Infection Treatment Market Drivers
Table 13. Upper Respiratory Tract Infection Treatment Market Challenges
Table 14. Upper Respiratory Tract Infection Treatment Market Restraints
Table 15. Global Upper Respiratory Tract Infection Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Upper Respiratory Tract Infection Treatment Market Share by Players (2016-2021)
Table 17. Global Top Upper Respiratory Tract Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Upper Respiratory Tract Infection Treatment as of 2020)
Table 18. Ranking of Global Top Upper Respiratory Tract Infection Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Upper Respiratory Tract Infection Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Upper Respiratory Tract Infection Treatment Product Solution and Service
Table 22. Date of Enter into Upper Respiratory Tract Infection Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Upper Respiratory Tract Infection Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Upper Respiratory Tract Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Upper Respiratory Tract Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Upper Respiratory Tract Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Upper Respiratory Tract Infection Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Upper Respiratory Tract Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Upper Respiratory Tract Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Upper Respiratory Tract Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Upper Respiratory Tract Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Upper Respiratory Tract Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Upper Respiratory Tract Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Upper Respiratory Tract Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Upper Respiratory Tract Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Upper Respiratory Tract Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Upper Respiratory Tract Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Upper Respiratory Tract Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Upper Respiratory Tract Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Upper Respiratory Tract Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Upper Respiratory Tract Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline Plc Company Details
Table 63. GlaxoSmithKline Plc Business Overview
Table 64. GlaxoSmithKline Plc Upper Respiratory Tract Infection Treatment Product
Table 65. GlaxoSmithKline Plc Revenue in Upper Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline Plc Recent Development
Table 67. Merck & Co., Inc. Company Details
Table 68. Merck & Co., Inc. Business Overview
Table 69. Merck & Co., Inc. Upper Respiratory Tract Infection Treatment Product
Table 70. Merck & Co., Inc. Revenue in Upper Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 71. Merck & Co., Inc. Recent Development
Table 72. Pfizer Inc. Company Details
Table 73. Pfizer Inc. Business Overview
Table 74. Pfizer Inc. Upper Respiratory Tract Infection Treatment Product
Table 75. Pfizer Inc. Revenue in Upper Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 76. Pfizer Inc. Recent Development
Table 77. Regeneron Pharmaceuticals Inc. Company Details
Table 78. Regeneron Pharmaceuticals Inc. Business Overview
Table 79. Regeneron Pharmaceuticals Inc. Upper Respiratory Tract Infection Treatment Product
Table 80. Regeneron Pharmaceuticals Inc. Revenue in Upper Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 81. Regeneron Pharmaceuticals Inc. Recent Development
Table 82. Teva Pharmaceutical Industries Ltd. Company Details
Table 83. Teva Pharmaceutical Industries Ltd. Business Overview
Table 84. Teva Pharmaceutical Industries Ltd. Upper Respiratory Tract Infection Treatment Product
Table 85. Teva Pharmaceutical Industries Ltd. Revenue in Upper Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 86. Teva Pharmaceutical Industries Ltd. Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Upper Respiratory Tract Infection Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Nasal Decongestants Features
Figure 4. Others Features
Figure 5. Global Upper Respiratory Tract Infection Treatment Market Share by Application: 2020 VS 2027
Figure 6. Rhinitis Case Studies
Figure 7. Sinusitis Case Studies
Figure 8. Nasopharyngitis Case Studies
Figure 9. Epiglottitis Case Studies
Figure 10. Laryngitis Case Studies
Figure 11. Whooping Cough Case Studies
Figure 12. Others Case Studies
Figure 13. Upper Respiratory Tract Infection Treatment Report Years Considered
Figure 14. Global Upper Respiratory Tract Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Upper Respiratory Tract Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Upper Respiratory Tract Infection Treatment Market Share by Regions: 2020 VS 2027
Figure 17. Global Upper Respiratory Tract Infection Treatment Market Share by Regions (2022-2027)
Figure 18. Global Upper Respiratory Tract Infection Treatment Market Share by Players in 2020
Figure 19. Global Top Upper Respiratory Tract Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Upper Respiratory Tract Infection Treatment as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Upper Respiratory Tract Infection Treatment Revenue in 2020
Figure 21. Global Upper Respiratory Tract Infection Treatment Revenue Market Share by Type (2016-2021)
Figure 22. Global Upper Respiratory Tract Infection Treatment Revenue Market Share by Type (2022-2027)
Figure 23. North America Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Upper Respiratory Tract Infection Treatment Market Share by Type (2016-2027)
Figure 25. North America Upper Respiratory Tract Infection Treatment Market Share by Application (2016-2027)
Figure 26. North America Upper Respiratory Tract Infection Treatment Market Share by Country (2016-2027)
Figure 27. United States Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Upper Respiratory Tract Infection Treatment Market Share by Type (2016-2027)
Figure 31. Europe Upper Respiratory Tract Infection Treatment Market Share by Application (2016-2027)
Figure 32. Europe Upper Respiratory Tract Infection Treatment Market Share by Country (2016-2027)
Figure 33. Germany Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Upper Respiratory Tract Infection Treatment Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Upper Respiratory Tract Infection Treatment Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Upper Respiratory Tract Infection Treatment Market Share by Region (2016-2027)
Figure 43. China Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Upper Respiratory Tract Infection Treatment Market Share by Type (2016-2027)
Figure 51. Latin America Upper Respiratory Tract Infection Treatment Market Share by Application (2016-2027)
Figure 52. Latin America Upper Respiratory Tract Infection Treatment Market Share by Country (2016-2027)
Figure 53. Mexico Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Upper Respiratory Tract Infection Treatment Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Upper Respiratory Tract Infection Treatment Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Upper Respiratory Tract Infection Treatment Market Share by Country (2016-2027)
Figure 59. Turkey Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Upper Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. GlaxoSmithKline Plc Revenue Growth Rate in Upper Respiratory Tract Infection Treatment Business (2016-2021)
Figure 63. Merck & Co., Inc. Revenue Growth Rate in Upper Respiratory Tract Infection Treatment Business (2016-2021)
Figure 64. Pfizer Inc. Revenue Growth Rate in Upper Respiratory Tract Infection Treatment Business (2016-2021)
Figure 65. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Upper Respiratory Tract Infection Treatment Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Upper Respiratory Tract Infection Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の気道感染症（RTI）治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Tract infections (RTIs) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4818 2021年6月 115Pages
QYResearch社発行の本調査レポートでは、気道感染症（RTI）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、錠剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の尿路感染症検査市場規模・現状・予測（2021年-2027年）

Global Urinary Tract Infection Testing Market Size, Status and Forecast 2021-2027
QFJ1-5001 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、尿路感染症検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腎・膀胱超音波式尿路感染症検査、膀胱鏡式尿路感染症検査、その他）、用途別市場規模（病院、診断研究所、研究所、その他）、主要地域別市場規模（...

世界の呼吸器感染症診断市場規模・現状・予測（2021年-2027年）

Global Respiratory Infection Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-5333 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、呼吸器感染症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（微生物、PCR、NGS、イムノアッセイ）、用途別市場規模（病院研究室、外来研究室）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の呼吸器抗ウイルス治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Antiviral Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4815 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、呼吸器抗ウイルス治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インフルエンザ、細気管支炎、肺炎、上気道感染症（URTI）、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域...

世界のボツリヌス菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Clostridium Botulinum Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4028 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ボツリヌス菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗毒素療法、細心気道管理、人工呼吸補助）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の小児HIV感染症治療市場規模・現状・予測（2021年-2027年）

Global Pediatric HIV Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5935 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、小児HIV感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（無症状、軽症、中症、重症）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他）、主要地域別市場規模（北米、...

世界の羊膜感染症治療市場規模・現状・予測（2021年-2027年）

Global Intra-amniotic Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5807 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、羊膜感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゲンタマイシン、クリンダマイシン、メトロニダゾール、その他）、用途別市場規模（病院・専門クリニック、外来手術センター、病院薬局、小売薬局、...

世界のブドウ球菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Staphylococcal Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4899 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ブドウ球菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射液）、用途別市場規模（黄色ブドウ球菌感染症、表皮ブドウ球菌感染症、サプロコッカス感染症）、主要地域別市場規模（北米、アメ...

世界のスポロトリクスシェンキー感染症治療市場規模・現状・予測（2021年-2027年）

Global Sporothrix Schenckii Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4897 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、スポロトリクスシェンキー感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イトラコナゾール薬、アムホテリシンB薬、ヨウ化カリウム飽和溶液（SSKI）、手術、その他）、用途別市場規模（病院、専門...

世界の胆道障害治療市場規模・現状・予測（2021年-2027年）

Global Biliary Tract Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5617 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、胆道障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の気道感染症（RTI）治療市場規模・現状・予測（2021年-2027年） Respiratory Infections Treatment can affect the sinuses, throat, airways or lungs. Market Analysis and Insights: Global Respiratory Tract infections (RTIs) Treatment Market The global Respiratory Tract infections (RTIs) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX …
世界の小動物呼吸器疾患治療市場規模・現状・予測（2021年-2027年） According to veterinary medical experts, upper respiratory infections– also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks. Market Analysis and Insights: Global Small Animals Respiratory Dis…
世界の尿路感染症検査市場規模・現状・予測（2021年-2027年） A urinary tract infection (UTI) is an infection that affects part of the urinary tract. Market Analysis and Insights: Global Urinary Tract Infection Testing Market The global Urinary Tract Infection Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a C…
世界の副鼻腔炎治療薬市場規模・現状・予測（2021年-2027年） Sinusitis is an inflammation or swelling of the tissue lining the sinuses. Market Analysis and Insights: Global Sinusitis Treatment Drugs Market The global Sinusitis Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-20…
世界の呼吸器感染症診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Respiratory Infection Diagnostic Market The global Respiratory Infection Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…